APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.

This paper examines how age intervenes in the effects of APOE ɛ4 allele on the volume and shape morphometrics of the hippocampus and the amygdala in mild cognitive impairment (MCI) and Alzheimer's disease. We evaluate the structural morphological differences between ɛ4 carriers and non-carriers in two age-dependent subgroups; younger than 75 years (Young-Old) and older than 80 years (Very-Old). While we show that the four structures of interest atrophy significantly in the ɛ4 carriers, relative to the non-carriers, of the Young-Old group, this effect is not observed in their Very-Old counterparts. The structures in the right hemisphere are found to be more affected by the APOE genotype than those in the left hemisphere and we identify the relevant regions in which significant atrophy occurs to be parts of the basolateral, centromedial, and lateral nucleus subregions of the amygdala and the CA1 and subiculum subregions of the hippocampus. We also observe that the APOE genotype only affects MCI patients that deteriorated to dementia within 3 years while leaving their "non-converting" counterparts unaffected.

[1]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[2]  Michael I. Miller,et al.  Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type , 2006, NeuroImage.

[3]  L. Younes,et al.  Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease , 2014, NeuroImage: Clinical.

[4]  J. Hodges,et al.  Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.

[5]  D. Perani,et al.  MCI conversion to dementia and the APOE genotype , 2004, Neurology.

[6]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[7]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[8]  A. Dale,et al.  APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[9]  H. Soininen,et al.  Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease , 1996, Neurology.

[10]  D. Delis,et al.  Neuropsychological deficits associated with Alzheimer's disease in the very-old: Discrepancies in raw vs. standardized scores , 2003, Journal of the International Neuropsychological Society.

[11]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[12]  Jun Ma,et al.  A Bayesian Generative Model for Surface Template Estimation , 2010, Int. J. Biomed. Imaging.

[13]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[14]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[15]  M. J. Wade,et al.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.

[16]  Jun Ma,et al.  Atlas Generation for Subcortical and Ventricular Structures With Its Applications in Shape Analysis , 2010, IEEE Transactions on Image Processing.

[17]  A. Dale,et al.  Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease , 2011, Neurology.

[18]  David S. Lee,et al.  The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.

[19]  Stian Lydersen,et al.  APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway , 2008, BMC neurology.

[20]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[21]  T. Ohm,et al.  Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology , 2004, Neurobiology of Aging.

[22]  David A Wolk,et al.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease , 2010, Proceedings of the National Academy of Sciences.

[23]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes , 1995, Neuroscience.

[24]  C. DeCarli,et al.  APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. , 1999, Neurology.

[25]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[26]  et al.,et al.  Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline , 2008, NeuroImage.

[27]  Thomas E. Nichols,et al.  Controlling the familywise error rate in functional neuroimaging: a comparative review , 2003, Statistical methods in medical research.

[28]  M. Bondi,et al.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors , 2015, Alzheimer's & Dementia.

[29]  B T Hyman,et al.  Entorhinal cortex pathology in Alzheimer's disease , 1991, Hippocampus.

[30]  Magda Tsolaki,et al.  Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts , 2014, Brain Topography.

[31]  L. Younes,et al.  Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting , 2014, Human brain mapping.

[32]  Jeffrey D. Bernstein,et al.  APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory , 2014, Neurology.

[33]  Anders M. Dale,et al.  Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data , 2006, NeuroImage.

[34]  C. DeCarli,et al.  Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[35]  H C Charles,et al.  Impact of APOE in mild cognitive impairment , 2004, Neurology.

[36]  F. Vogel,et al.  The limbic system in Alzheimer's disease. A neuropathologic investigation. , 1976, The American journal of pathology.

[37]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[38]  R. Mayeux,et al.  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.

[39]  Christopher H. van Dyck,et al.  Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease , 2000, Neurobiology of Aging.

[40]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[41]  Massimo Filippi,et al.  Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia , 2009, Proceedings of the National Academy of Sciences.

[42]  Charles DeCarli,et al.  Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment , 2003, The Lancet Neurology.

[43]  D. Loewenstein,et al.  Mild cognitive impairment , 2003, Neurology.

[44]  B. Hyman,et al.  Neuroanatomy of Alzheimer's disease: Hierarchical vulnerability and neural system compromise , 1995, Neurobiology of Aging.

[45]  Joan Alexis Glaunès,et al.  Surface Matching via Currents , 2005, IPMI.

[46]  Nicolas Cherbuin,et al.  Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.

[47]  Michael I. Miller,et al.  Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort , 2015, Neurobiology of Aging.

[48]  D. Salmon,et al.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. , 2014, Journal of Alzheimer's disease : JAD.

[49]  C. Cuénod,et al.  Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. , 1993, Archives of neurology.

[50]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[51]  C. Jack,et al.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers , 2008, Brain : a journal of neurology.

[52]  Martin Klein,et al.  Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype , 2007, Dementia and Geriatric Cognitive Disorders.

[53]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[54]  Xiaoying Tang,et al.  The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease , 2015, Human brain mapping.

[55]  Paul M. Thompson,et al.  APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease , 2011, NeuroImage.

[56]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[57]  Xiaoying Tang,et al.  Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[58]  A. Dale,et al.  Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers , 2013, American Journal of Neuroradiology.

[59]  J. Bohl,et al.  Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease , 2002, Acta Neuropathologica.

[60]  Jonas Persson,et al.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ɛ4: Relation to chronological age and recognition memory , 2006, Neuroscience Letters.

[61]  R. Sulkava,et al.  APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old , 2000, Neurology.

[62]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.